SUZANNE TOMPKINS: Open Payments
NPI 1871965236 · CENTREVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$615 in 33 payments from 13 companies in 2025. Trend: 2023 $1,519 · 2024 $884 · 2025 $615
Food & beverage: $615
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $144 |
| Novo Nordisk Inc | 6 | $108 |
| AstraZeneca Pharmaceuticals LP | 5 | $79 |
| Lilly USA, LLC | 5 | $73 |
| ABBVIE INC. | 2 | $58 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
| Corium, LLC | 1 | $24 |
| Ossur Americas, Inc. | 1 | $22 |
| Phathom Pharmaceuticals, Inc. | 1 | $21 |
| Exact Sciences Corporation | 1 | $15 |
Products named: Kerendia, Ozempic, FARXIGA, MOUNJARO, UBRELVY, JARDIANCE, REXULTI, Azstarys.
Industry payments across AL — which companies pay providers there.
